Ocular Safety Testing: Choosing Evidence Without Defaulting to One Test
By Global Regulatory Submissions Inc.
Why Ocular Safety Matters
Products used near the eye—or products that may contact the eye accidentally—require careful assessment of irritation and serious-eye-damage potential. The relevant question depends on the product, exposure, market, and claim. A rinse-off shampoo, facial serum, eye-area cosmetic, household chemical, and medical device solution do not share one universal test plan.
Start With Existing Information
A sound strategy reviews ingredient classifications, concentration, pH, buffering capacity, physical form, structure–activity information, historical data, exposure, and validated information from comparable materials. The purpose is to identify whether a conclusion can be reached and what uncertainty remains before additional testing.
In-Vitro and Defined Approaches
OECD test guidelines describe several methods and defined approaches relevant to eye irritation or serious eye damage, including reconstructed human cornea-like epithelium and other in-vitro systems. Each method has a defined applicability domain and prediction capability. Some identify severe hazards; others identify materials not requiring classification; a combination may be needed.
OECD guidance on integrated approaches supports combining evidence in a structured way. The choice should follow the applicable regulatory framework, product matrix, and decision context rather than using “ocular testing” as a single generic service.
Responsible Study Planning
Testing plans should state the regulatory question, test article preparation, method suitability, controls, acceptance criteria, and decision logic. Consider formulation features that can interfere with a method. Results should be interpreted by qualified experts and connected to the product’s safety assessment, label warnings, and use instructions.
Global Regulatory Submissions Inc. can help map market expectations, coordinate qualified laboratories, and organize the resulting reports within the broader compliance file.
Disclaimer: This article provides general informational content and does not constitute legal, medical, toxicological, or regulatory advice. Requirements vary by product, claim, market, and jurisdiction and should be confirmed against current legislation and agency guidance.
